O Babusikova

Summary

Affiliation: Slovak Academy of Sciences
Country: Slovakia

Publications

  1. ncbi The value of multiparameter flow cytometry of cerebrospinal fluid involved by leukemia/lymphoma cells
    O Babusikova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 51:345-51. 2004
  2. ncbi The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia
    O Babusikova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 52:502-9. 2005
  3. ncbi Hairy cell leukemia: early immunophenotypical detection and quantitative analysis by flow cytometry
    O Babusikova
    Cancer Research Institute Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 50:350-6. 2003
  4. ncbi The analogy in cell immunophenotype and parameters of cell cycle of ectopic thymus, normal thymus, and some acute lymphoblastic leukemia of T-phenotype
    O Babusikova
    Cancer Research Institute Slovak Academy of Sciences, Bratislava, 83391 Slovakia
    Neoplasma 49:312-8. 2002
  5. ncbi Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment
    O Babusikova
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 48:350-7. 2001
  6. ncbi Correlation of clinical picture (event free survival and overall survival) in childhood acute leukemia patients with immunophenotype and chromosomal abnormalities
    O Babusikova
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 47:382-9. 2000
  7. ncbi Immunophenotyping parameters as prognostic factors in T-acute leukemia patients
    O Babusikova
    Cancer Researc Institute and Center for Molecular Medicine, Slovak Academy of Sciences, Bratislava, Slovakia
    Neoplasma 56:508-13. 2009
  8. ncbi Analysis of surface and cytoplasmic immunoglobulin light/heavy chains by flow cytometry using a lysed-whole-blood technique: Implications for the differential diagnosis of B-cell malignancies
    O Babusikova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 51:422-30. 2004
  9. ncbi The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry
    T Zeleznikova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 52:517-22. 2005
  10. ncbi The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia
    T Zeleznikova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 53:500-6. 2006

Collaborators

Detail Information

Publications24

  1. ncbi The value of multiparameter flow cytometry of cerebrospinal fluid involved by leukemia/lymphoma cells
    O Babusikova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 51:345-51. 2004
    ..Simultaneously we demonstrated that FC analysis of CSF in the aim to detect possible CSF seeding of leukemia/lymphoma is a reliable and quick technique...
  2. ncbi The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia
    O Babusikova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 52:502-9. 2005
    ..Increased information on benign B-lymphocyte precursors, especially that of existence of the 3rd type hematogones could provide a basis for better discrimination of B-leukemia cells even in a very small amounts...
  3. ncbi Hairy cell leukemia: early immunophenotypical detection and quantitative analysis by flow cytometry
    O Babusikova
    Cancer Research Institute Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 50:350-6. 2003
    ..A long-term decline of CD4+ T-cells correlated with the relatively low incidence of clinical progression of HCL...
  4. ncbi The analogy in cell immunophenotype and parameters of cell cycle of ectopic thymus, normal thymus, and some acute lymphoblastic leukemia of T-phenotype
    O Babusikova
    Cancer Research Institute Slovak Academy of Sciences, Bratislava, 83391 Slovakia
    Neoplasma 49:312-8. 2002
    ....
  5. ncbi Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment
    O Babusikova
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 48:350-7. 2001
    ....
  6. ncbi Correlation of clinical picture (event free survival and overall survival) in childhood acute leukemia patients with immunophenotype and chromosomal abnormalities
    O Babusikova
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 47:382-9. 2000
    ..The presence/absence of CD34 marker expression in blast cells of our group of acute leukemia patients did not show any difference in event free survival and overall survival rates...
  7. ncbi Immunophenotyping parameters as prognostic factors in T-acute leukemia patients
    O Babusikova
    Cancer Researc Institute and Center for Molecular Medicine, Slovak Academy of Sciences, Bratislava, Slovakia
    Neoplasma 56:508-13. 2009
    ..The results have been discussed with similar the most relevant immunophenotypic results of others and mainly with gene-expressing profiling associated with a significantly worse clinical outcome...
  8. ncbi Analysis of surface and cytoplasmic immunoglobulin light/heavy chains by flow cytometry using a lysed-whole-blood technique: Implications for the differential diagnosis of B-cell malignancies
    O Babusikova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 51:422-30. 2004
    ....
  9. ncbi The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry
    T Zeleznikova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 52:517-22. 2005
    ....
  10. ncbi The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia
    T Zeleznikova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 53:500-6. 2006
    ..In conclusion, investigation of MRD should be based on the phenotypic characteristics of each subpopulation even if it is present in low frequencies...
  11. ncbi Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia
    T Zeleznikova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 54:471-7. 2007
    ....
  12. ncbi Shifts in expression of immunological cell markers in relapsed acute leukemia
    A Tomova
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 48:164-8. 2001
    ..The shifts (loss or acquisition) in expression of individual markers at relapse are bound with the first diagnosis and may have a relationship to the treatment and are important for correct assessment of minimal residual disease...
  13. ncbi Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment
    J Kusenda
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 51:97-102. 2004
    ..Quantitative analysis of some markers in B-CLL cells seems to offer valuable information concerning possible influence of some chemotherapeutics on antigen equipment of leukemic cells...
  14. ncbi Possible prognostic value of nucleolar morphology in pathologic cells of B-chronic lymphocytic leukemia
    M Klobusicka
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 57:429-37. 2010
    ..The simplicity and utility of the nucleolar test as a possible prognostic parameter may help to identify the subset of patients with early B-CLL disease that will run a more progressive course...
  15. ncbi Multiparametric flow cytometry in detection of minimal residual disease in acute lymphoblastic leukemia of early B-cell phenotype
    A Mlcáková
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 50:416-21. 2003
    ..We also verified that in some cases the CD58 marker is overexpressed on CD10+, CD34+ blast cells at diagnosis and can be feasible used for detection of minimal residual disease (MRD)...
  16. ncbi Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis
    M Klobusicka
    Cancer Research Institute, Slovak Academy of Sciences, 83391 Bratislava, Slovak Republic
    Neoplasma 52:211-8. 2005
    ....
  17. ncbi Immunophenotype characterization of hematopoietic stem cells, progenitor cells restricted to myeloid lineage and their leukemia counterparts
    M Fajtova
    Slovak Academy of Sciences, Bratislava, Slovakia
    Neoplasma 57:392-400. 2010
    ....
  18. ncbi Amplification of AML1 gene in association with karyotype, age and diagnosis in acute leukemia patients
    G Kirschnerová
    Cancer Research Institute, Slovak Academy of Sciences, 83391 Bratislava, Slovak Republic
    Neoplasma 53:150-4. 2006
    ..True high-level amplification was not observed but some uncommon changes in noteworthy association with other chromosome aberrations, age or diagnoses were presented...
  19. ncbi Normal maturation sequence of immunoglobulin light and heavy chains in hematogone stages 1, 2 and 3 in acute leukemia after treatment
    O Babusikova
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia
    Neoplasma 55:501-6. 2008
    ..Light Ig chains kappa/lambda were expressed in a polytypic way. The results completed information on normal maturation sequence of bone marrow stage 1, 2 and 3 hematogone regeneration in treated acute leukemia patients...
  20. ncbi Expression of p53 and bcl-2 proteins in acute leukemias: an immunocytochemical study
    M Klobusicka
    Cancer Research Institute Slovak Academy of Sciences, Bratislava
    Neoplasma 48:489-95. 2001
    ..Although our preliminary results need to be confirmed in a larger group of patients, immunocytochemical analysis of p53 and Bcl-2 proteins, indicators of cell alterations, may help to identify risk patients requiring intensive therapy...
  21. ncbi Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients
    M Klobusicka
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 49:387-93. 2002
    ..Thus it would be possible to confirm our expectation of a possible value of the simultaneous aberrant expression of bcl-2 and p53 as useful predictors of future aggressive behavior of B-CLL...
  22. ncbi Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients
    M Klobusicka
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 50:408-15. 2003
    ..Larger studies are needed in order to consolidate these preliminary results and characterize the possible prognostic value of AgNOR in association with p53 and bcl-2 proteins expression...
  23. ncbi CD26 and DPP IV expression in T acute lymphoblastic leukemia cells: immunocytochemistry and enzyme cytochemistry
    M Klobusicka
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Gen Physiol Biophys 18:34-7. 1999
    ..The results provide information of CD26 antigen possible involvement in the pathology of leukemic cells via its DPP IV enzyme activity...
  24. ncbi A novel quasi-viral agent, MaTu, is a two-component system
    S Pastorekova
    Institute of Virology, Slovak Academy of Sciences, Bratislava
    Virology 187:620-6. 1992
    ..Both p54/58N peptides are glycosylated and they form oligomers linked by disulfidic bonds; p58X is not glycosylated and it does not form S-S-linked oligomers...